Lecture: management of chemotherapy-induced febrile neutropenia; guidelines and colony stimulating factors.

Giuseppe Procopio, Monica Niger, Isabella Testa

Research output: Contribution to journalArticle

Abstract

Chemotherapy-induced febrile neutropenia (FN) is a major risk factor for severe infections potentially fatal, and also a dose-limiting toxicity, so causing dose reductions and/or delays in scheduled chemotherapy. This lecture provides recommendations for the use of G-CSF in adult cancer patients at risk of chemotherapy-induced FN. If expected risk of FN is equal or superior to 20%, a primary prophylaxis of FN with G-CSF is recommended. Primary prophylaxis can be considered in case of intermediate 10-20% risk of FN, in presence of factors that increase the frequency/risk of FN, such as age >65, advanced disease, prior episode of FN, poor performance status, radiotherapy to a wide body area (>20%). In case of low risk of FN (

Original languageEnglish
JournalNeurological Sciences
Volume32 Suppl 2
Publication statusPublished - Nov 2011

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Lecture: management of chemotherapy-induced febrile neutropenia; guidelines and colony stimulating factors.'. Together they form a unique fingerprint.

  • Cite this